The present invention is directed to pharmaceutical compositions of an inhibitor of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders.La presente invención se dirige a composiciones farmacéuticas de un inhibidor de indolamina 2,3-dioxigenasa y son útiles para el tratamiento del cáncer y otros trastornos.